Remdesivir is a direct-acting antiviral that inhibits RNA-dependent RNA polymerase from severe acute respiratory syndrome coronavirus 2 with high potency

por Gordon, Calvin J., Tchesnokov, Egor P., Woolner, Emma, Perry, Jason K., Feng, Joy Y., Porter, Danielle P., Götte, Matthias
Publicado 2020

Template-dependent inhibition of coronavirus RNA-dependent RNA polymerase by remdesivir reveals a second mechanism of action

por Tchesnokov, Egor P., Gordon, Calvin J., Woolner, Emma, Kocinkova, Dana, Perry, Jason K., Feng, Joy Y., Porter, Danielle P., Götte, Matthias
Publicado 2020

Correction: Template-dependent inhibition of coronavirus RNA-dependent RNA polymerase by remdesivir reveals a second mechanism of action

por Tchesnokov, Egor P., Gordon, Calvin J., Woolner, Emma, Kocincova, Dana, Perry, Jason K., Feng, Joy Y., Porter, Danielle P., Götte, Matthias
Publicado 2021

Quantitative in vivo whole genome motility screen reveals novel therapeutic targets to block cancer metastasis

por Stoletov, Konstantin, Willetts, Lian, Paproski, Robert J., Bond, David J., Raha, Srijan, Jovel, Juan, Adam, Benjamin, Robertson, Amy E., Wong, Francis, Woolner, Emma, Sosnowski, Deborah L., Bismar, Tarek A., Wong, Gane Ka-Shu, Zijlstra, Andries, Lewis, John D.
Publicado 2018